Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TMO | +18.13% | −0.33% | +0.48% | +4.25% | +18.95% | +45.74% | +20.73% | +54.01% | +8.84% | +129.12% | +362.56% | +362.56% |
| K-GHEALTH | +8.68% | +2.43% | +4.12% | +9.71% | +7.39% | +15.70% | +14.91% | +23.85% | −1.08% | +45.66% | +94.42% | +94.42% |
| TGHSTARP | +8.02% | +2.58% | +4.74% | +8.05% | +7.59% | +15.80% | +15.53% | +21.24% | −1.82% | +34.66% | +70.65% | +70.65% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes TMO: money market or bond funds, or no holdings data yet
| K-GHEALTH | TGHSTARP | |
|---|---|---|
| Held by both | ||
 Eli Lilly and Co | 8.17% | 5.91% |
 Johnson & Johnson | 6.43% | 5.32% |
 ABBVIE | 7.45% | 4.03% |
 Merck & | 5.41% | 3.66% |
 Thermo Fisher | 4.70% | 2.55% |
 Novartis | 4.59% | 2.52% |
 Unitedhealth Group | 3.37% | 1.95% |
| Only in K-GHEALTH | ||
 AstraZeneca | 4.19% | N/A |
 Abbott Laboratories | 2.96% | N/A |
 Danaher | 2.96% | N/A |
| Only in TGHSTARP | ||
 Roche | N/A | 3.00% |
 Gilead Sciences | N/A | 2.31% |
 Amgen | N/A | 2.03% |
30 Dec 2025 → 2 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| TMO | +18.13% | 31.18% | 0.58 |
| K-GHEALTH | +8.68% | 15.48% | 0.56 |
| TGHSTARP | +8.02% | 14.98% | 0.54 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | TMO | K-GHEALTH | TGHSTARP |
|---|---|---|---|
Fund details | |||
| Fund size | N/A | 3,130 million | 155 million |
| Inception date | N/A | 26 Nov 2014 | 20 May 2015 |
| Master fund | N/A | JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD | กองทุนที่ลงทุนหลายกอง (BlackRock Global Funds - World Healthscience) |
| Dividend policy | N/A | Pays | Does not pay |
Risk and currency hedging | |||
| Risk level | N/A | 6 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 93.16% | 91.65% |
Minimum purchase and redemption | |||
| First purchase | N/A | 500 THB | 1,000 THB |
| Subsequent purchase | N/A | 500 THB | 1,000 THB |
| Redemption (amount) | N/A | 500 THB | No minimum |
| Redemption (units) | N/A | No minimum | No minimum |
| Balance (amount) | N/A | 50 THB | No minimum |
| Balance (units) | N/A | No minimum | 100 units |
Order cut-off and redemption payment | |||
| Buy before | N/A | 15:30 | 15:30 |
| Redeem before | N/A | 14:30 | 15:30 |
| Redemption paid | N/A | T+4 | T+5 |
